Thursday, July 9, 2026

Did U.S. Forces Really Complain? South Korea’s Defense Minister Sets the Record Straight!

Defense Minister Ahn Gyu-baek denied USFK commander's protest over comments on North Korean nuclear facilities, emphasizing ongoing communication.

North Korean Medical Experts Illegally Work in Russia: What You Need to Know

North Korean doctors are reportedly working illegally in Russia and Central Asia, raising concerns over UN sanctions violations.

NVIDIA’s $56M Investment Boosts Nebius Stock by Nearly 7%

NVIDIA's $56M investment in AI firm Nebius boosted its stock by nearly 7%, highlighting growing interest in AI technologies.

Tag: AriBio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

Unlocking the Future of Neuroscience: AriBio’s Partnership with Lilly TuneLab for Advanced AI Drug Development

AriBio partners with Eli Lilly's AI platform, Lilly TuneLab, to enhance drug development for neurodegenerative diseases using advanced AI.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.